CFMS - Conformis, Inc.
| Previous Close | 2.0200 |
| Open | 2.0200 |
| Bid | 1.9000 x 800 |
| Ask | 1.9100 x 900 |
| Day's Range | 1.8550 - 2.0600 |
| 52 Week Range | 0.3580 - 4.8300 |
| Volume | 665,241 |
| Avg. Volume | 1,430,076 |
| Market Cap | 131.176M |
| Beta (3Y Monthly) | 1.85 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5150 |
| Earnings Date | Jul 31, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.13 |
- ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Conformis, Inc. - CFMS
NEW YORK, NY / ACCESSWIRE / August 7, 2019 / Pomerantz LLP is investigating claims on behalf of investors of Conformis, Inc. (“Conformis” or the “Company”) (CFMS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether Conformis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Conformis, Inc. (CFMS)
NEW YORK , Aug. 6, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Conformis, Inc. ("Conformis" or ...
- Thomson Reuters StreetEvents
Edited Transcript of CFMS earnings conference call or presentation 31-Jul-19 8:30pm GMT
Q2 2019 Conformis Inc Earnings Call
- Zacks
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates
ConforMIS (CFMS) delivered earnings and revenue surprises of 0.00% and 1.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Conformis Reports Second Quarter 2019 Financial Results and Updates Product Revenue Expectations
BILLERICA, Mass., July 31, 2019 -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop,.
- Zacks
ConforMIS (CFMS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire
Conformis Establishes Alliance to Focus on ASC Joint Replacement
BILLERICA, Mass., July 15, 2019 -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop,.
- GlobeNewswire
Conformis to Host Second Quarter 2019 Financial Results Webcast on July 31, 2019
BILLERICA, Mass., July 15, 2019 -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, July 31, 2019, at 4:30 p.m. Eastern Time to discuss.
- Zacks
Hottest Wall Street Stories of First Half
We discuss some of the events that dominated the headlines in the first half and influenced the market.
- GlobeNewswire
Conformis Secures Up to $30 Million in Debt Financing and $3 Million in Equity Financing from Innovatus Life Sciences and East West Bank
Conformis, Inc. (CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique anatomy, announced today that the Company has secured up to $30 million in debt financing from Innovatus Capital Partners, LLC (“Innovatus”) and East West Bank and $3 million in equity financing from Innovatus. This financing is part of Conformis’ comprehensive financing strategy to optimize its capital structure and to provide the funding for driving its commercialization. Conformis will use the proceeds from the debt financing to payoff the $15 million term loan from Oxford Finance LLC and currently expects that the remainder will be used for general corporate purposes, including but not limited to funding its working capital needs.
- Investopedia
3 Stocks Under $5 Hitting New Highs
These low-priced stocks are attracting healthy buying interest despite sub-par small-cap performance so far in 2019.
- Simply Wall St.
Introducing Conformis (NASDAQ:CFMS), The Stock That Zoomed 170% In The Last Year
Unless you borrow money to invest, the potential losses are limited. But when you pick a company that is really...
- Thomson Reuters StreetEvents
Edited Transcript of CFMS earnings conference call or presentation 1-May-19 8:30pm GMT
Q1 2019 Conformis Inc Earnings Call
- Zacks
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates
ConforMIS (CFMS) delivered earnings and revenue surprises of 0.00% and 2.64%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press
ConforMIS: 1Q Earnings Snapshot
On a per-share basis, the Billerica, Massachusetts-based company said it had a loss of 12 cents. The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...
- GlobeNewswire
Conformis Reports First Quarter 2019 Financial Results
BILLERICA, Mass., May 01, 2019 -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop,.
- Zacks
Can iTotal PS Revenues Drive ConforMIS' (CFMS) Q1 Earnings?
ConforMIS (CFMS) expects to register solid revenue growth on robust performance by its product lines as well as steady royalties.
- GlobeNewswire
New Peer Reviewed Data Supports Use of Conformis Customized Knee Implants to Match Anatomic Variability in Patients
Publically available information on the design for standard or off-the-shelf (“OTS”) symmetric and fixed asymmetric implants was analyzed against the data derived from patient CT scans in this study. The results demonstrated that the OTS implant designs would not match the patient knee geometry and therefore, would not address or account for the femoral offset geometries in more than half of the patients’ population in this study.
- GlobeNewswire
Conformis to Host First Quarter 2019 Financial Results Webcast on May 1, 2019
BILLERICA, Mass., April 17, 2019 -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, May 1, 2019, at 4:30 p.m. Eastern Time to discuss.
- ACCESSWIRE
These Tech Stocks Could Test March Highs
CORAL GABLES, FL / ACCESSWIRE / March 18, 2019 / The tech stock market is truly miraculous, mainly because the tech industry never ceases to amaze consumers as companies consistently demonstrate their ability to innovate towards the future. Over the course of the last few months, we've seen tech companies design and invent in the areas of data analytics, artificial intelligence, augmented reality, and a plethora of others. ParcelPal Technology Inc (PTNYF) (PKG), Conformis Inc (CFMS), Digital Turbine Inc (APPS), and Akari Therapeutics Plc (AKTX) represent 4 tech stocks on the rise on Monday.
- ACCESSWIRE
Four Healthcare Stocks Picking Up Speed On Friday
CORAL GABLES, FL / ACCESSWIRE / March 15, 2019 / The future successes of the healthcare stock market are intrinsically entwined with whether, or not, healthcare companies are aptly prepared to rise to ...
- Simply Wall St.
What Do Analysts Think About The Future Of Conformis, Inc.’s (NASDAQ:CFMS)?
Conformis, Inc.'s (NASDAQ:CFMS) announced its latest earnings update in December 2018, which signalled that losses became smaller relative to the prior year's level as a result of recent tailwinds Below,Read More...
